文献速递心境障碍

抑郁症肠脑轴中的色氨酸代谢:机制、异质性关联与治疗机遇

Tryptophan metabolism within the gut-brain axis in depression: mechanisms, association with heterogeneity, and therapeutic opportunities.
PubMed 文献 · Mol Psychiatry · 2026-10-29

本综述阐述色氨酸三大代谢途径(犬尿氨酸、血清素、微生物吲哚途径)通过调节神经免疫信号、神经递质功能和肠脑通讯参与抑郁症病理生理与生物学异质性。微生物依赖性色氨酸代谢在不同临床、人口学、免疫代谢、创伤相关及遗传定义的抑郁表型中呈现不同特征,并评述了靶向该代谢的药物治疗、营养、微生物及中药干预策略。

要点

  • 色氨酸代谢紊乱通过肠脑轴参与抑郁症病理生理与生物学异质性。
  • 犬尿氨酸、血清素和微生物吲哚途径调节神经免疫、神经递质与肠脑通讯。
  • 微生物依赖性色氨酸代谢谱在不同抑郁表型间存在差异,支持精准诊疗。

核心结论

  • 色氨酸代谢紊乱经肠脑轴参与抑郁症病理生理,并可作为抑郁异质性的统一生物学框架。

研究设计与样本

  • 综述,汇总色氨酸三大代谢途径在抑郁症中的作用及靶向治疗证据。

主要发现

  • 犬尿氨酸、血清素和微生物吲哚途径调节神经免疫信号、神经递质功能和肠脑通讯。
  • 微生物依赖性色氨酸代谢在临床、人口学、免疫代谢、创伤相关及遗传定义的抑郁表型中呈现不同特征。

关键数值与推荐

  • 微生物依赖性色氨酸代谢谱在不同抑郁表型间存在差异,支持其作为抑郁异质性的生物学框架。

临床怎么用

  • 靶向微生物相关色氨酸代谢的药物、营养、微生物及中药干预策略具有治疗潜力。

局限性

  • 需整合多组学、纵向设计及人工智能机制验证以阐明因果关系并推动生物标志物与精准治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Depression is a highly heterogeneous psychiatric disorder, characterized by substantial variability in clinical manifestations, treatment responses, and disease progression, thereby posing significant challenges to precision diagnosis and therapeutic intervention. Accumulating evidence indicates that dysregulated tryptophan metabolism, mediated through dynamic crosstalk with the gut microbiota and the gut-brain axis (GBA), plays a pivotal role in both the pathophysiology and biological heterogeneity of depression. In this review, we delineate the contributions of the three principal tryptophan metabolic pathways-the kynurenine, serotonin, and microbial indole pathways-in modulating neuroimmune signaling, neurotransmitter function, and gut-brain communication. Moreover, we synthesize current evidence demonstrating that microbiota-dependent tryptophan metabolism exhibits distinct profiles across clinical, demographic, immunometabolic, trauma-related, and genetically defined depressive phenotypes, thereby establishing its role as a unifying biological framework underlying depressive heterogeneity. We further provide a critical appraisal of emerging therapeutic strategies targeting microbiota-associated tryptophan metabolism, including pharmacological, nutritional, microbial, and traditional Chinese medicine-based interventions. Future investigations should integrate multi-omics approaches, longitudinal study designs, and mechanistic validation with artificial intelligence to elucidate causal relationships between microbiota-associated tryptophan metabolism and depressive heterogeneity, ultimately facilitating biomarker discovery and the development of precision therapeutics.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Qin, Lei, Yi, et al. Tryptophan metabolism within the gut-brain axis in depression: mechanisms, association with heterogeneity, and therapeutic opportunities. Mol Psychiatry. 2026. PMID: 42957828. doi:10.1038/s41380-026-03948-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。